本システムでは、JavaScriptを利用しています。JavaScriptを有効に設定してからご利用ください。

【参】六角形画像(NEWS)

H1

NEWS

パンくずリスト

ホーム > Kidswell Bio Corporation > NEWS

★IR：カテゴリメニュー

タブV2

All
IR Library
Topics

2022/08/31

IR Library

[Presentation] SHED Master Cell Bank completed [PDF：2431KB]
2022/08/16

IR Library

Company note 1Q FY2023/3 update from OMEGA Investment [PDF：826KB]
2022/08/05

IR Library

[Presentation] Financial Results for the First Quarter of FY2022 [PDF：2431KB]
2022/08/05

IR Library

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023 (Extracted from Japanese version) [PDF：468KB]
2022/06/23

IR Library

Financial Measures for Increased Orders of GBS-007 [PDF：1589KB]
2022/05/26

IR Library

[Presentation] Medium Term Strategic Plan -KWB2.0- (Full version) [PDF：3950KB]
2022/05/26

IR Library

Announcement of research collaboration agreement with Chiome Bioscience Inc. for the development of antibody drugs (Extracted from Japanese version)

[PDF：91KB]
2022/05/20

IR Library

Company Research and Analysis Report from OMEGA Investment [PDF：311KB]
2022/05/12

IRIR Library

Company note 4Q update from OMEGA Investment [PDF：245KB]
2022/05/12

IRIR Library

[Presentation] Financial Results for the FY 2021 [PDF：2994KB]
2022/05/12

IRIR Library

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (Extracted from Japanese version) [PDF：721KB]
2022/05/12

IRIR Library

Announcement of Appointment of Accounting Auditor [PDF：126KB]
2022/04/04

IR Library

Announcement of execution of share transfer agreement of the consolidated subsidiary and share purchase agreement with Metcela Inc., and change in the purpose of the 10th share acquisition rights due to this transaction (Extracted from Japanese version)
[PDF：291KB]
2022/03/24

IR Library

Omega Bioscience Index has been released by OMEGA Investment Co., Ltd.
2022/03/17

IRIR Library

Column about SHED (Stem cells from Human Exfoliated Deciduous teeth) has posted in the website of AMED iD3 Catalyst Unit.
2022/03/07

IRIR Library

Company note 3Q update from OMEGA Investment [PDF：523KB]
2022/02/04

IRIR Library

[Presentation] Financial Results for the Third Quarter of FY2021 [PDF：1670KB]
2022/02/04

IRIR Library

Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022
[PDF：469KB]
2022/01/26

IR Library

Announcement of business alliance agreement with Metcela Inc. for the regenerative medicine business [PDF：207KB]
2021/12/09

お知らせIR Library

Announcement of the launch of Ranibizumab BS [PDF：120KB]
2021/11/25

お知らせIR Library

Company note 2Q update from OMEGA Investment [PDF：274KB]
2021/11/05

お知らせ決算短信IR Library

Summary of Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2021 [PDF：470KB]
2021/11/05

IR Library

[Presentation] Financial Results for the Second Quarter of FY2021 [PDF：2373KB]
2021/10/21

IR Library

Announcement of extraordinary income (gain on sale of investment securities) and revisions of the consolidated financial forecast for the FY 2021 [PDF：191KB]
2021/09/28

IR Library

Company Research and Analysis Report from OMEGA Investment [PDF：4959KB]
2021/09/27

IR Library

Announcement of Receiving Manufacturing and Sales Approval for biosimilar in the Ophthalmic Area in Japan [PDF：119KB]
2021/09/08

IR Library

Announcement of collaborative research agreement with NanoCarrier Co., Ltd. for development of a designer cell as reinforced cell therapy utilizing SHED [PDF：251KB]
2021/08/12

IRIR Library

[Presentation] Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 [PDF：2274KB]
2021/08/12

IRIR Library

Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 [PDF：456KB]
2021/05/17

IR Library

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 [PDF：435KB]
2021/02/15

IR Library

Summary of Our Mid-Term Strategic Plan from FY2021 to FY2025 [PDF：1678KB]
2021/01/22

IR Library

Our mid-term strategic plan will be announced on Feb. 15.
2021/01/05

IR Library

Interview video of Masaharu Tani, CEO, has been released at Sessa TV.
2020/11/09

IR Library

Summary of Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2021 [PDF：596KB]
2020/11/09

IR Library

FY2020 2Q IR Meeting Information [PDF：3730KB]
2020/09/18

IR Library

Announcement of Application for Approval of Manufacturing and Sales in Japan for biosimilar in the Ophthalmic Area [PDF：254KB]
2020/08/20

IR Library

Announcement of Joint Research Agreement with Hokkaido University and Spinal Injuries Center for Non-Union Fractures [PDF：255KB]
2020/07/15

IR Library

New business alliance with Dojin Group to accelerate research and development of regenerative medicine products by using SHED and expand SHED-related business [PDF：631KB]
2020/05/25

IR Library

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 [PDF：480KB]
2020/05/25

IR Library

FY2019 IR Meeting Information [PDF：1450KB]
2020/04/08

IR Library

Announcement of completion of issuance of the 3rd series of convertible bond with stock acquisition rights and the 10th series of stock acquisition rights [PDF：336KB]
2020/03/23

IR Library

[Presentation] Establishment of manufacturing process for the master cell bank and business alliance with Mochida Pharma, and Financing for driving JRM-001 [PDF：763KB]
2020/03/16

IR Library

Announcement of Establishment of Manufacturing Process for Master Cell Bank Based on the Business Partnership with NIKON CORPORATION

[PDF：122KB]
2020/03/05

IR Library

Announcement of Joint Research Agreement with Oita University for Peripheral Nerve Paralysis [PDF：176KB]
2020/03/05

IR Library

Announcement of Joint Research Agreement with Nagoya University for Spinal Cord Injury [PDF：146KB]
2020/02/19

IR Library

End of Observation Period for the Last Patient in Phase III Clinical Trial of Biosimilar Product for Ophthalmic Treatment in Japan Developed with Senju Pharmaceutical Co., Ltd.

[PDF：128KB]
2020/02/17

IR Library

[Presentation] Announcement of Acquisition of Shares of Japan Regenerative Medicine Co., Ltd. [PDF：763KB]
2020/02/17

IR Library

[Document] Announcement of Acquisition of Shares of Japan Regenerative Medicine Co., Ltd. [PDF：182KB]
2020/02/14

IR Library

Announcement of Business Alliance Agreement with DOJIN GROUP Co, Ltd. for business development in regenerative medicine and healthcare area [PDF：124KB]
2020/02/05

IR Library

FY2019 3Q IR Meeting Information [PDF：1828KB]

前へ
1
2
3
4
5
次へ

2025/11/25

IR Library

Signing of an Agreement to Establish a Joint Venture for the Manufacture of Biosimilars [PDF：262KB]
2025/11/25

IR Library

Confirming Alignment on the Cerebral Palsy Clinical Trial Plan at the Pre-IND Meeting with U.S. FDA (SQ-SHED's Overseas Development) [PDF：144KB]
2025/11/17

IR Library

Interim Results of SHED Clinical Study for Children with Cerebral Palsy Disclosed by Nagoya University [PDF：222KB]
2025/11/13

IR Library

Financial Results for FY2025 Q2 [PDF：1445KB]
2025/11/13

IR Library

Summary of Consolidated Financial Results for 2Q of the Fiscal Year Ended March 31, 2026 [PDF：338KB]
2025/10/29

IR Library

"Treg" with "SHED" Toward the Development of an Innovative Immune Cell Therapy -Joint Research Agreement with Tokyo University of Science- [PDF：141KB]
2025/10/16

IR Library

Toward a New Infertility Treatment Utilizing SHED - Commencement of Joint Research with LYMPHOGENiX (UK) - [PDF：176KB]
2025/10/08

IR Library

Collaborative Research Results with S-Quatre to be Presented by Nagoya University at the 75th Congress of Neurological Surgeons in Los Angels (CNS 2025)
2025/10/07

IR Library

SHED Clinical Study for Cerebral Palsy Data Safety Monitoring Board Confirms "No Safety Concerns" [PDF：240KB]
2025/10/06

IR Library

Execution of Agreements regarding the Joint Development of Biosimilars for Specified Products [PDF：102KB]

1
2
3
4
5
6
7
8
9
10
次へ

2019/11/22

topics

Announcement on Series B Funding by Heartseed Inc.
2019/05/10

topics

Notice of Relocation of Head Office Function, Relocation of Tokyo Office, and Integration of Subsidiaries office [PDF：137KB]
2019/05/10

topics

Announcement of signing a joint research and development agreement with ORTHOREBIRTH for cleft lip/cleft palate [PDF：198KB]
2019/03/12

topics

Notice of Resolutions at the Extraordinary General Shareholders Meeting [PDF：297KB]
2019/02/28

topics

Completion of the enrollment of the final patient in the Phase III study for ophthalmologic biosimilar [PDF：78KB]
2019/02/05

topics

FY2018 3Q IR Meeting Information [PDF：2408KB]
2019/01/31

topics

GTS and Senju sign a licensing agreement with Ocumension Therapeutics on biosimilar in ophthalmologic field [PDF：93KB]
2019/01/17

topics

[Presentation] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：1833KB]
2019/01/17

topics

[Announcement] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：348KB]
2018/09/28

topics

Submission of New Drug Application in Japan of Darbepoetin alfa Biosimilar [PDF：169KB]

1
2
3
4
次へ